New insights into how genetic variants influence disease risk

FHS
July 25, 2024
6:44 am

A new study by scientists at deCODE Genetics, a subsidiary of Amgen, shows that sequence variants drive the correlation between DNA methylation and gene expression. The same variants are linked to various diseases and other human traits.

Celcuity teams up with Bayer for Phase Ib/II prostate cancer trial – Pharmaceutical Technology

Celcuity is planning a Phase Ib/II trial for its prostate cancer therapy. Credit: FatCamera via Getty Images. US-based Celcuity has announced a new clinical trial

August 23, 2023

Aficamten improves exercise tolerance in patients with HOCM

Exercise intolerance is often severe among patients with cardiovascular disease and can impose significant limitations on their physical abilities and quality of life. Medications known

September 5, 2024

Deeper Sedation During Colonoscopy Linked to Improved Detection of Serrated Polyps

Detection of serrated polyps during colonoscopy improved significantly with the use of propofol-based versus conventional sedation, data from a large registry showed. The detection rate

April 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.